Exposure to rosiglitazone and fluoxetine in the first trimester of pregnancy.
Choi
June-Seek
JS
Han
Jung-Yeol
JY
Ahn
Hyun-Kyong
HK
Shin
Joong-Sik
JS
Yang
Jae-Hyug
JH
Koong
Mi-Kyoung
MK
Nava-Ocampo
Alejandro A
AA
D000328:Adult; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011256:Pregnancy Outcome; D011261:Pregnancy Trimester, First; D000077154:Rosiglitazone; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D045162:Thiazolidinediones / Q000627:therapeutic use*
D005473:Fluoxetine; D007004:Hypoglycemic Agents; D000077154:Rosiglitazone; D017367:Selective Serotonin Reuptake Inhibitors; D045162:Thiazolidinediones